Frank Takkinen
Stock Analyst at Lake Street
(1.00)
# 3,965
Out of 5,182 analysts
79
Total ratings
29.17%
Success rate
-15.64%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Maintains: Buy | $40 → $50 | $41.99 | +19.08% | 3 | Apr 23, 2026 | |
| SMTI Sanara MedTech | Initiates: Buy | $32 | $18.70 | +71.12% | 1 | Apr 15, 2026 | |
| TELA TELA Bio | Maintains: Buy | $3 → $2 | $0.78 | +156.41% | 4 | Mar 25, 2026 | |
| HYPR Hyperfine | Maintains: Buy | $2 → $2.5 | $1.30 | +92.31% | 3 | Mar 19, 2026 | |
| TNDM Tandem Diabetes Care | Upgrades: Buy | $50 | $18.63 | +168.38% | 1 | Feb 23, 2026 | |
| NOTV Inotiv | Maintains: Buy | $3 → $1.5 | $0.29 | +420.65% | 9 | Feb 10, 2026 | |
| RCEL AVITA Medical | Maintains: Hold | $3 → $3.5 | $4.33 | -19.17% | 2 | Jan 16, 2026 | |
| BBNX Beta Bionics | Maintains: Buy | $35 → $40 | $10.08 | +296.83% | 2 | Jan 9, 2026 | |
| KRMD KORU Medical Systems | Maintains: Buy | $6 → $8 | $4.08 | +96.08% | 3 | Dec 22, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $7 → $12 | $4.36 | +175.23% | 7 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.09 | +266.97% | 1 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.23 | +225.20% | 3 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $1.01 | +494.06% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $150 | $55.11 | +172.18% | 2 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $10.98 | +118.58% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $14 | $7.48 | +87.17% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $15 | $5.35 | +180.37% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $26 | $12.68 | +105.05% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $11.08 | +170.76% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $5.68 | +252.11% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.14 | +338.60% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $36.33 | -17.42% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $0.63 | +846.07% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.86 | +115.05% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $16.89 | -28.95% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $3.67 | +145.23% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $3.28 | +387.80% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $923 → $277 | $8.94 | +2,997.32% | 2 | Jan 18, 2023 |
Axogen
Apr 23, 2026
Maintains: Buy
Price Target: $40 → $50
Current: $41.99
Upside: +19.08%
Sanara MedTech
Apr 15, 2026
Initiates: Buy
Price Target: $32
Current: $18.70
Upside: +71.12%
TELA Bio
Mar 25, 2026
Maintains: Buy
Price Target: $3 → $2
Current: $0.78
Upside: +156.41%
Hyperfine
Mar 19, 2026
Maintains: Buy
Price Target: $2 → $2.5
Current: $1.30
Upside: +92.31%
Tandem Diabetes Care
Feb 23, 2026
Upgrades: Buy
Price Target: $50
Current: $18.63
Upside: +168.38%
Inotiv
Feb 10, 2026
Maintains: Buy
Price Target: $3 → $1.5
Current: $0.29
Upside: +420.65%
AVITA Medical
Jan 16, 2026
Maintains: Hold
Price Target: $3 → $3.5
Current: $4.33
Upside: -19.17%
Beta Bionics
Jan 9, 2026
Maintains: Buy
Price Target: $35 → $40
Current: $10.08
Upside: +296.83%
KORU Medical Systems
Dec 22, 2025
Maintains: Buy
Price Target: $6 → $8
Current: $4.08
Upside: +96.08%
Sight Sciences
Dec 10, 2025
Maintains: Buy
Price Target: $7 → $12
Current: $4.36
Upside: +175.23%
Dec 2, 2025
Initiates: Buy
Price Target: $4
Current: $1.09
Upside: +266.97%
Oct 28, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.23
Upside: +225.20%
Sep 10, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $1.01
Upside: +494.06%
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $150
Current: $55.11
Upside: +172.18%
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $10.98
Upside: +118.58%
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $7.48
Upside: +87.17%
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $5.35
Upside: +180.37%
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $12.68
Upside: +105.05%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $11.08
Upside: +170.76%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $5.68
Upside: +252.11%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $1.14
Upside: +338.60%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $36.33
Upside: -17.42%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $0.63
Upside: +846.07%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $1.86
Upside: +115.05%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $16.89
Upside: -28.95%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $3.67
Upside: +145.23%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $3.28
Upside: +387.80%
Jan 18, 2023
Maintains: Buy
Price Target: $923 → $277
Current: $8.94
Upside: +2,997.32%